Weekly Conferences | From San Diego to Shanghai: Insilico Medicine showcases new advances in AI-driven drug discovery - EurekAlert!
Bridging technology and clinic: Insilico Medicine at Morgan Stanley China Biopharma Symposium 2026 - EurekAlert!
Insilico Medicine to showcase AI-driven innovation at BIO 2026 International Convention - EurekAlert!
Advancing drug discovery from automation to autonomy: Insilico Medicine announces LabClaw The Intelligent System - EurekAlert!
Generative AI leap: Insilico Medicine nominates first preclinical candidate in the UAE - EurekAlert!
Insilico Medicine announces industry’s first longevity board to accelerate AI-driven aging research for drug discovery - EurekAlert!
Insilico Medicine advances AI-driven target discovery with validated TargetPro–TargetBench framework - EurekAlert!
Insilico Medicine expands MMAI Gym with benchmark leaderboard portals for scientific research and drug discovery - EurekAlert!
Insilico Medicine and Tenacia Biotechnology expand AI-driven CNS collaboration with deal Value up to US $94.75 million - EurekAlert!
Insilico Medicine named to Fast Company’s annual list of the world’s most innovative companies of 2026 - EurekAlert!
Insilico Medicine launches PandaClaw: Empowering biologists with agentic AI for therapeutic discovery - EurekAlert!
Insilico Medicine announces inclusion in Hang Seng Index and Stock Connect program - EurekAlert!
ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D - EurekAlert!
Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers - EurekAlert!
Insilico Medicine featured in Harvard Business School case on Rentosertib - EurekAlert!
AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases - EurekAlert!
Insilico Medicine appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology - EurekAlert!
Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research - EurekAlert!
Insilico Medicine receives USD 5 million milestone payment from Menarini Group following First-in-Human (FIH) achievement for MEN2501 - EurekAlert!
Insilico Medicine and Qilu Pharmaceutical reach near $120 million drug development collaboration to accelerate novel cardiometabolic therapies - EurekAlert!
